Optimizing antibiotic therapy of group IV community-acquired pneumonia patients

Optimizing antibiotic therapy of group IV community-acquired pneumonia patients

The aim of the study was to evaluate the clinical and economical effectiveness of differentiated antibacterial therapy of group IV patients with community-acquired pneumonia (CAP). Materials and methods. 42 patients, admitted to the hospital with severe CAP without risk factors for P. aeruginosa inf...

Full description

Bibliographic Details
Main Author:	Dziublyk Ya.O.
Format:	Article
Language:	English
Published:	Dnipro State Medical University 2014-06-01
Series:	Medičnì Perspektivi
Subjects:	community-acquired pneumonia antibiotics effectiveness of treatment cost
Online Access:	http://medpers.dsma.dp.ua/issues/2014/N2/32-38.pdf

Similar Items

Influence of antibiotics of different groups on the course of community-acquired pneumonia in children
by: N.Yu. Shcherbatiuk, et al.
Published: (2022-12-01)

Cost-effectiveness analysis of empiric antibiotics in hospitalized community-acquired Pneumonia
by: Yeni Farida, et al.
Published: (2022-03-01)

Community-Acquired Pneumonia in Children: Current Approaches to the Duration of Antibiotic Therapy
by: S.O. Mokiia-Serbina, et al.
Published: (2016-03-01)

The effect of taking antibacterial therapy on the outpatient stage and outcomes of community-acquired pneumonia in Tomsk hospitals
by: Daria A. Vinokurova, et al.
Published: (2024-01-01)

Antibiotic therapy of choice for community-acquired pneumonia in Malaysian Hajj pilgrims: the pattern and associated factors
by: Diana Dzaraly, et al.
Published: (2017-09-01)

Short antibiotic courses in community-acquired pneumonia in adults: less is better
by: A. I. Sinopalnikov
Published: (2018-10-01)

Management of community-acquired bacterial pneumonia in adults: Limitations of current antibiotics and future therapies
by: Sandeep Nayar, et al.
Published: (2019-01-01)

Tigecycline and Community-Acquired Pneumonia
by: Sercan ULUSOY
Published: (2013-12-01)

Azithromycin Place in the Therapy of Community-Acquired Pneumonia in Children
by: S.A. Kramarev
Published: (2013-03-01)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
by: Mariana Lopes, et al.
Published: (2021-01-01)

Adherence to Guidelines for Assessment and Empiric Antibiotics Recommendations for Community-Acquired Pneumonia at Ambo University Referral Hospital: Prospective Observational Study
by: Eticha EM, et al.
Published: (2021-02-01)

Antibiotic therapy regimens for mild community-acquired pneumonia in patients with risk factors for ineffective treatment: Clinical and economic comparisons
by: A A Zaĭtsev, et al.
Published: (2013-12-01)

Community-acquired pneumonia /
by: Suttorp, N. (Norbert), 1953-, et al.
Published: (2007)

Empiric antibiotic therapy in the treatment of community-acquired pneumonia in a general hospital in Saudi Arabia
by: Jaffar A Al-Tawfiq, et al.
Published: (2019-01-01)

Assessment of Treatment of Community Acquired Severe Pneumonia by Two Different Antibiotics
by: Karimeldin MA Salih, et al.
Published: (2016-05-01)

Pharmacoeconomic research of pharmacotherapy schemes of community-acquired pneumonia with the inclusion of antiviral drugs
by: S. O. Soloviov, et al.
Published: (2020-03-01)

Mycoplasma pneumoniae: Atypical Pathogen in Community Acquired Pneumonia
by: Abdul-Rahman Mamdouh Mohammad, et al.
Published: (2020-12-01)

Evidence for short duration of antibiotic treatment for non-severe community acquired pneumonia (CAP) in children - are we there yet? A systematic review of randomised controlled trials
by: Shalom Ben-Shimol, et al.
Published: (2014-03-01)

Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study
by: Pauline Guillot, et al.
Published: (2023-09-01)

The real life application of a procalcitonin-based algorithm to reduce antibiotic exposure in hospitalized patients with community acquired pneumonia: a proof of concept
by: Filippo Pieralli, et al.
Published: (2016-09-01)

Dilemma of community-acquired pneumonia
by: Lamia H Shaaban
Published: (2019-01-01)

Effects of a clinical pathway on antibiotic use in patients with community-acquired pneumonia: a multi-site study in China
by: Liping Zhu, et al.
Published: (2018-09-01)

Community-acquired pneumonia in children: antibacterial therapy
by: Y. L. Mizernitsky
Published: (2013-12-01)

The impact of a stewardship program on antibiotic administration in community-acquired pneumonia: Results from an observational before-after study
by: Markus Fally, et al.
Published: (2021-02-01)

Analysis of antibiotic prescriptions in patients with community-acquired pneumonia in clinical practice
by: Taube A.A., et al.
Published: (2022-12-01)

PLACE OF RESPIRATORY FLUOROQUINOLONES IN THERAPY OF COMMUNITY ACQUIRED PNEUMONIA: FOCUS ON HIGH-DOSE LEVOFLOXACINE THERAPEUTIC REGIME
by: A. I. Sinopalnikov
Published: (2017-11-01)

Management of Community-Acquired Pneumonia in Immunocompetent Adults in Turkey
by: Hakan ERDEM, et al.
Published: (2007-06-01)

Evaluation of a Pediatric Community-Acquired Pneumonia Antimicrobial Stewardship Intervention at an Academic Medical Center
by: Lauren Puzz, et al.
Published: (2023-04-01)

FASTCAP study on the management of hospitalized patients with community-acquired pneumonia: pharmacoeconomic analysis of the prospective phase
by: C. Lazzaro, et al.
Published: (2013-05-01)

Features of laboratory indicators of severe community-acquired pneumonia
by: Pertzeva T.A., et al.
Published: (2017-06-01)

QUANTITATIV ANALYSIS AND PHARMACOECONOMICS OF ANTIBIOTIC USE IN COMMUNITY-ACQUIRED PNEUMONIA (CAP) IN PKU MUHAMMADIYAH GAMPING
by: Ayunda Putri Hadiningrat, et al.
Published: (2021-05-01)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
by: O. V. Muslimova, et al.
Published: (2022-07-01)

PROBLEMS OF ANTIBIOTIC THERAPY IN KOVID-ASSOCIATED HOSPITAL PNEUMONIA
by: O.A. Savchenko, et al.
Published: (2022-06-01)

Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy
by: Donald BJ, et al.
Published: (2017-12-01)

Antibiotic Use and Treatment Outcomes among Children with Community-Acquired Pneumonia Admitted to a Tertiary Care Public Hospital in Nepal
by: Bhishma Pokhrel, et al.
Published: (2021-04-01)

EXPERIENCE OF RESPIRATORY FLUOROHINOLONUM LAEVOFLOXACINE APPLICATION («FLORACID®») IN PATIENTS WITH NON-SEVERE COMMUNITY-ACQUIRED PNEUMONIA
by: A.P. Rebrov, et al.
Published: (2007-09-01)

Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland
by: Kristina Keitel, et al.
Published: (2014-03-01)

Burden of community-acquired pneumonia in adults over 18 y of age
by: Filiz Kosar, et al.
Published: (2017-07-01)

Features of Clinical and X-ray Patterns of Community-Acquired Pneumonia in Children in Various Age Groups
by: Semernik OE, et al.
Published: (2019-01-01)

Antibiotic therapy of community-acquired pneumonia in children: comparison of international guidelines and current practice in Ukraine
by: S.L. Nyankovskyy, et al.
Published: (2018-11-01)